Fan et al. specified that administration of EZH2 siRNA into glioma cells effectively as well as quickly silenced EZH2 resulting in a reduction in mRNA and protein levels by about 70%, signifying the effective inhibitory effects of EZH2 siRNA [9]. This evidence concerns the gene EZH2 and central nervous system cancer.